Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Aethlon Medical (AEMD)

Aethlon Medical (AEMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 75,357
  • Shares Outstanding, K 15,379
  • Annual Sales, $ 660 K
  • Annual Income, $ -7,890 K
  • 60-Month Beta 0.65
  • Price/Sales 113.65
  • Price/Cash Flow N/A
  • Price/Book 6.87
Trade AEMD with:

Options Overview

Details
  • Implied Volatility 159.98%
  • Historical Volatility 135.34%
  • IV Percentile 4%
  • IV Rank 0.94%
  • IV High 262.21% on 07/01/21
  • IV Low 159.01% on 07/26/21
  • Put/Call Vol Ratio 0.48
  • Today's Volume 189
  • Volume Avg (30-Day) 522
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 3,325
  • Open Int (30-Day) 2,087

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.13
  • Number of Estimates 2
  • High Estimate -0.10
  • Low Estimate -0.15
  • Prior Year -0.15
  • Growth Rate Est. (year over year) +13.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.49 +40.40%
on 07/14/21
6.22 -21.22%
on 07/22/21
-0.02 (-0.41%)
since 06/30/21
3-Month
1.45 +237.93%
on 05/13/21
12.49 -60.77%
on 06/09/21
+3.08 (+169.23%)
since 04/30/21
52-Week
1.22 +301.97%
on 09/04/20
12.49 -60.77%
on 06/09/21
+2.82 (+135.58%)
since 07/30/20

Most Recent Stories

More News
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2021

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its first quarter...

AEMD : 4.90 (+0.62%)
Thinking about buying stock in Tempest Therapeutics, Cemtrex, Exela Technologies, Aethlon Medical, or Bridgeline Digital?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TPST, CETX, XELA, AEMD, and BLIN.

AEMD : 4.90 (+0.62%)
BLIN : 6.40 (+8.84%)
CETX : 1.2800 (-2.29%)
XELA : 2.63 (+1.15%)
TPST : 15.02 (-2.97%)
Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, today reported financial results...

AEMD : 4.90 (+0.62%)
Aethlon Medical to Release Fourth Quarter Financial Results and Host Conference Call on June 24, 2021

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its fourth quarter...

AEMD : 4.90 (+0.62%)
Thinking about buying stock in Trxade Health, Clean Energy Fuels, Athene, TAL Education Group, or Aethlon Medical?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MEDS, CLNE, ATH, TAL, and AEMD.

CLNE : 7.51 (-1.57%)
MEDS : 4.97 (unch)
AEMD : 4.90 (+0.62%)
ATH : 64.62 (-0.98%)
TAL : 6.07 (+3.41%)
Aethlon Medical Announces $12.425 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq:AEMD), a medical device technology company focused on unmet needs in global health, today announced that it has entered into a definitive agreement with...

AEMD : 4.90 (+0.62%)
Thinking about buying stock in Aethlon Medical, Checkpoint Therapeutics, ContextLogic, Clean Energy Fuels, or Solid Biosciences?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AEMD, CKPT, WISH, CLNE, and SLDB.

CLNE : 7.51 (-1.57%)
WISH : 9.94 (-0.40%)
AEMD : 4.90 (+0.62%)
CKPT : 2.63 (-1.13%)
SLDB : 2.79 (+0.36%)
Aethlon Medical Publishes Case Studies of Two Critically Ill COVID-19 Patients Treated with the Hemopurifier®

, /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced the publication of a pre-print manuscript highlighting...

AEMD : 4.90 (+0.62%)
Aethlon Medical to Participate in Two Upcoming Healthcare Investor Conferences

, /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that the company will participate in the H.C. Wainwright...

AEMD : 4.90 (+0.62%)
Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

, /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device therapeutic company focused on developing products to diagnose and treat life and organ threatening diseases,  today reported...

AEMD : 4.90 (+0.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Aethlon Medical, Inc. is a development stage medical device company focused on expanding the applications of our Hemopurifier (R) platform technology, which is designed to rapidly reduce the presence of infectious viruses and other toxins from human blood. In this regard, its core focus is the development...

See More

Key Turning Points

3rd Resistance Point 5.34
2nd Resistance Point 5.22
1st Resistance Point 5.06
Last Price 4.90
1st Support Level 4.78
2nd Support Level 4.66
3rd Support Level 4.50

See More

52-Week High 12.49
Fibonacci 61.8% 8.18
Fibonacci 50% 6.85
Fibonacci 38.2% 5.52
Last Price 4.90
52-Week Low 1.22

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar